|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-3-2
|
|
pubmed:abstractText |
Hepatocellular carcinoma (HCC) is an aggressive malignancy with few treatment options. As the status of the tumour immune microenvironment can affect progression of established tumours, we evaluated potential immune mechanisms associated with survival in HCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AbastadoJean-PierreJP,
pubmed-author:BolzeAlexandreA,
pubmed-author:ChanJasmineJ,
pubmed-author:ChewValerieV,
pubmed-author:GehringAdamA,
pubmed-author:LeeKang HoeKH,
pubmed-author:LeeVictor K MVK,
pubmed-author:LohMarieM,
pubmed-author:NardinAlessandraA,
pubmed-author:QuekRichardR,
pubmed-author:TeoMarissaM,
pubmed-author:TohHan ChongHC,
pubmed-author:TowCharleneC,
pubmed-author:WongHing LokHL
|
|
pubmed:copyrightInfo |
Copyright (c) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19720422-Adult,
pubmed-meshheading:19720422-Aged,
pubmed-meshheading:19720422-Aged, 80 and over,
pubmed-meshheading:19720422-CD8-Positive T-Lymphocytes,
pubmed-meshheading:19720422-Carcinoma, Hepatocellular,
pubmed-meshheading:19720422-Cell Line, Tumor,
pubmed-meshheading:19720422-Cell Proliferation,
pubmed-meshheading:19720422-Chemokine CCL2,
pubmed-meshheading:19720422-Female,
pubmed-meshheading:19720422-Humans,
pubmed-meshheading:19720422-Immune System,
pubmed-meshheading:19720422-Inflammation,
pubmed-meshheading:19720422-Interleukin-6,
pubmed-meshheading:19720422-Killer Cells, Natural,
pubmed-meshheading:19720422-Liver Neoplasms,
pubmed-meshheading:19720422-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:19720422-Male,
pubmed-meshheading:19720422-Middle Aged,
pubmed-meshheading:19720422-Prognosis,
pubmed-meshheading:19720422-Retrospective Studies,
pubmed-meshheading:19720422-Survival Rate,
pubmed-meshheading:19720422-Tumor Markers, Biological,
pubmed-meshheading:19720422-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
|
|
pubmed:affiliation |
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Biopolis, Immunos #04-00, 8A Biomedical Grove, Singapore.
|
|
pubmed:publicationType |
Journal Article
|
